{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:58:49Z","timestamp":1792022329603,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00c3\u00b6r\u00c2\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.atherosclerosis.2015.01.023","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T23:32:33Z","timestamp":1422401553000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy"],"prefix":"10.1016","volume":"239","author":[{"given":"Giuseppe","family":"Asciutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno V.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Edsfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnar","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla N.","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.STR.22.6.711","article-title":"North American symptomatic carotid endarterectomy Trial. Methods, patient characteristics, and progress","volume":"22","year":"1991","journal-title":"Stroke J. Cereb. Circ."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.1995.03520420037035","article-title":"Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study","volume":"273","year":"1995","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MOL.0b013e328356ec7c","article-title":"Apolipoprotein B100 autoimmunity and atherosclerosis \u2013 disease mechanisms and therapeutic potential","volume":"23","author":"Nilsson","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib4","doi-asserted-by":"crossref","first-page":"15527","DOI":"10.1074\/jbc.R700054200","article-title":"Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity","volume":"283","author":"Hazen","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","article-title":"Role of oxidized low density lipoprotein in atherogenesis","volume":"88","author":"Witztum","year":"1991","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(94)90143-0","article-title":"Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II","volume":"107","author":"Keidar","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib7","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","article-title":"C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis","volume":"20","author":"Torzewski","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2009.06.005","article-title":"High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation","volume":"406","author":"Santos","year":"2009","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11883-999-0011-0","article-title":"Inflammation and immune response in atherosclerosis","volume":"1","author":"Hansson","year":"1999","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2796.2000.00656.x","article-title":"Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis","volume":"247","author":"Palinski","year":"2000","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2796.2000.00654.x","article-title":"Changing concepts of atherogenesis","volume":"247","author":"Libby","year":"2000","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib12","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.1994.00420220105012","article-title":"Antibody against oxidized low-density lipoprotein predicting myocardial infarction","volume":"154","author":"Puurunen","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.15.4.441","article-title":"Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL","volume":"15","author":"Bergmark","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/10715760500072156","article-title":"Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease","volume":"39","author":"Faviou","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.carpath.2013.04.005","article-title":"Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques","volume":"22","author":"Asciutto","year":"2013","journal-title":"Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.ATV.0000067935.02679.B0","article-title":"Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.atherosclerosis.2013.11.041","article-title":"Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis","volume":"232","author":"McLeod","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches","volume":"123","author":"Lichtman","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2796.2008.01945.x","article-title":"Autoimmunity in atherosclerosis: a protective response losing control?","volume":"263","author":"Nilsson","year":"2008","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI119681","article-title":"The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-\/- mice","volume":"100","author":"Daugherty","year":"1997","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcm.2007.03.001","article-title":"Regulatory T-cell immunity in atherosclerosis","volume":"17","author":"Mallat","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib25","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","article-title":"The role of natural antibodies in atherogenesis","volume":"46","author":"Binder","year":"2005","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib27","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/01.CIR.0000143162.56057.B5","article-title":"Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis","volume":"110","author":"Schiopu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib28","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2007.07.081","article-title":"Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-\/-)\/low-density lipoprotein receptor(-\/-) mice","volume":"50","author":"Schiopu","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.molmet.2013.06.001","article-title":"Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques","volume":"2","author":"Li","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00041433-200410000-00002","article-title":"Will autoantibodies help to determine severity and progression of atherosclerosis?","volume":"15","author":"Nilsson","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00125-009-1377-9","article-title":"Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes","volume":"52","author":"Fredrikson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2796.2011.02411.x","article-title":"High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes","volume":"271","author":"Engelbertsen","year":"2012","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib33","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.atherosclerosis.2006.12.014","article-title":"Autoantibody against the amino acid sequence 661\u2013680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events","volume":"194","author":"Fredrikson","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"Frostegard","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.01.023_bib35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/STROKEAHA.106.474577","article-title":"Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease","volume":"38","author":"Fredrikson","year":"2007","journal-title":"Stroke J. Cereb. Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501500057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501500057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:22:58Z","timestamp":1762186978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501500057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S002191501500057X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.023","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}